Indian Pharma Companies
-
{
- All
- News
- Videos
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
US Pharma Sector Demands Keeping India In Patent Violator List
Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others.
-
PM Modi Likely To Chair Meeting On FDI Roadmap On Tuesday: Report
The Prime Minister's Office has convened a meeting on June 21 to deliberate upon a roadmap for further easing FDI norms to attract more foreign investment.
-
Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report
Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.
-
US generic drug fee relief plan may benefit Indian companies
With the US Food and Drug Administration proposing to hike the fees for generic drug-makers for next fiscal, concerns had been raised on the financial burden that the one-size-fits-all fee structure creates issues for the smaller units, which typically face cash crunch problems.
-
India pharma companies should follow strict regulations: FDA
In its latest action against Indian drug makers, the US health regulator FDA had red- flagged "significant deviations" from good manufacturing practices by two Indian pharmaceutical companies: Hyderabad-based Posh Chemicals and Himachal Pradesh-based Sentiss Pharma (formerly Promed Exports).
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
US Pharma Sector Demands Keeping India In Patent Violator List
Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others.
-
PM Modi Likely To Chair Meeting On FDI Roadmap On Tuesday: Report
The Prime Minister's Office has convened a meeting on June 21 to deliberate upon a roadmap for further easing FDI norms to attract more foreign investment.
-
Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report
Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.
-
US generic drug fee relief plan may benefit Indian companies
With the US Food and Drug Administration proposing to hike the fees for generic drug-makers for next fiscal, concerns had been raised on the financial burden that the one-size-fits-all fee structure creates issues for the smaller units, which typically face cash crunch problems.
-
India pharma companies should follow strict regulations: FDA
In its latest action against Indian drug makers, the US health regulator FDA had red- flagged "significant deviations" from good manufacturing practices by two Indian pharmaceutical companies: Hyderabad-based Posh Chemicals and Himachal Pradesh-based Sentiss Pharma (formerly Promed Exports).
